Home Pilots RapidAI receives FDA 510(k) to identify potential pulmonary embolism Pilots RapidAI receives FDA 510(k) to identify potential pulmonary embolism By - May 24, 2022 38 0 Facebook Twitter Pinterest WhatsApp The Rapid PE Triage & Notification tool analyzes CT pulmonary angiograms to find potential cases and alert care teams. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Roundup: First insomnia DTx in South Korea gets regulatory nod and more briefs Pilots - February 17, 2023 0 Women’s health platform Maven Clinic scores $90M in funding Pilots - November 15, 2022 0 Sleepio becomes first digital therapeutic to receive NICE guidance Pilots - May 21, 2022 0 Medable snaps up dermatology-focused Omhu A/S Pilots - February 2, 2022 0 Baymatob secures $3M funding to complete its pilot study on AI labour monitoring device Pilots - March 30, 2022 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3